JPRN-jRCTs051180175已完成未知
Intravitreal bevacizumab injection for intraocular neovascularization in children - IVB for intraocular neovascularization in children
Ohnaka Masayuki0 个研究点目标入组 21 人开始时间: 2019年3月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
Bevacizumab therapy was considered to be a safe and effective treatment for retinopathy of prematurity, because there were no complications after the treatment and the timing of retinal photocoagulation was able to push off.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 year-old 至 12 years-old（—）
- 性别
- All
入选标准
- •1, Patients with diseases in which intraocular neovascular vessels do not disappear or reappeared after conventional therapy such as retinal photocoagulation
- •2, Retinopathy of prematurity, regardless of treatment, is zone I disease, zone II disease with stage 2+ or 3+, and aggressive posterior retinopathy of prematurity in the international classification
- •3, From 2 weeks old to 12 years old
- •4, Written informed consent by parents
排除标准
- •1, Patients with infarct disease, heart failure with poor control, hypertension, renal failure, abnormal blood coagulation ability, gastrointestinal ulcer
- •2, Patients who need to take other treatment priorities due to poor general condition
- •3. Patients who judged that neonatal specialists, pediatricians or the researcher are inappropriate as research subjects
- •4. Patients participating in other studies
研究者
相似试验
Unknown
不适用
Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.NCT01707745Sivakami A Pai50
已完成
不适用
Study for efficacy and safety of intravitreal injection of bevacizumab (Avastin)diabetic retinopathy central retinal vein occulusion, neovascular glaucomaJPRN-UMIN000012248ational Center for Global Health and Medicine, Kohnodai Hospital20
撤回
3 期
Intravitreal Bevacizumab for Inflammatory Neovascular MembranesVogt Koyanagi Harada DiseaseSerpiginous ChoroiditisMultifocal ChoroiditisNCT00407121Asociación para Evitar la Ceguera en México
已完成
不适用
Intravitreal bevacizumab injection for intraocular neovascularization in childreRetinopathy of prematurityJPRN-UMIN000014316Kansai Medical University15
Unknown
2 期
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of PrematurityRetinopathy of PrematurityNCT00622726The University of Texas Health Science Center, Houston150